Navigation Links
Breast Cancer Survivors Fail To Show Interest In Follow Up Mammogram

Women diagnosed with breast cancer no doubt receive best possible treatment for the deadly disease following the first one-year of treatment. It is recommended that such women receive a follow-up mammogram, to assess the treatment outcome. // This is to a large extent ignored by most early-stage breast cancer survivors, according to a latest study published in the Journal of Clinical Oncology.

Such mammograms can go a long way in the identification of any adverse effects associated with the cancer treatment and the early detection of secondary cancer, if any. Further, it can ensure that the breast cancer remains in remission. Currently, 815 breast cancer survivors exist for every 100,000 women in the United States.

Researchers from the Lombardi Comprehensive Cancer Center analyzed the primary treatment given to women with either stage I or stage II breast cancer. The study participants were required to provide extensive information about the health care provided following one year of treatment. Nearly 558 women were recruited for the study, out of which 391 were able to provide the requested information.

A close examination of the data revealed that the breast cancer survivors on an average utilized health care services approximately 30 times on an average compared to the general public. Visits to the cancer clinic were found to account for a major proportion of the treatment cost.

Furthermore, variations in the treatment strategies and costs, based on diverse geographic locations were documented. The presence of other concomitant diseases, the physical and mental health status (depression) of the cancer patient, was found to play a major role in determining the treatment modality. These factors were associated with increased visits and treatment costs.

Despite the fact that all these women should have had a mammography following the first one-year of treatment, only 62% of those studied w ere found to have had a mammogram. Comparatively, women treated by lumpectomy were more likely to have a mammogram than those with a history of mastectomy. The same effect was observed in white and nonwhite women. This could be attributed to a better educational status and increased health awareness among white women.

The results of the present study have several valuable implications. First, it highlights the existing lacunae in the diagnosis and treatment of breast cancer, amongst the so-called developed countries. Secondly, it necessitates an improvement in the use of mammography for monitoring breast cancer treatment. Finally, it must be ensured that all breast cancer survivors should be encouraged to actively participate in their treatment process that would result in a superior outcome.


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the ... management solution to the exhibit floor for the 2017 HIMSS Conference & ... From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's ... facets of clinical trial planning and management. Pharmica discussed the importance of effective ... addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets ... ESSA Pharma Inc. (Nasdaq: EPIX ). The ... Kumar Raja , PhD. ESSA Pharmaceuticals ... castration resistant prostate cancer (CRPC). Its lead compound EPI-506, ... the amino-terminal domain of the androgen receptor, thereby has ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today announced results ... Net income attributable to DaVita Inc. for the ... or $0.80 per share and $880 million, or $4.29 per ... DaVita Inc. for the quarter and year ended December 31, ... or $0.98 per share, and $789 million, or $3.85 per ...
Breaking Medicine Technology: